Drugs Archives - Page 38 of 67

KHN’s ‘What The Health?’: Tennessee Seeks Medicaid Changes

Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book “The Price We Pay” about why health care costs so much.

Sept. 19, 2019

Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle

Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.

By Mark Kreidler

Sept. 17, 2019

Purveyors Of Black-Market Pharmaceuticals Target Immigrants

Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.

By John M. Glionna

Sept. 16, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Sept. 13, 2019

Podcast

KHN’s ‘What The Health?’: Despite Booming Economy, Uninsured Rate Ticks Up

Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.

Sept. 12, 2019

Pharma Cash To Congress

Congress Rakes In Millions From Drugmakers

In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.

By Elizabeth Lucas

Sept. 12, 2019

Legislation To End Surprise Medical Bills Has High Public Support — In Both Parties

Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.

By Emmarie Huetteman

Sept. 12, 2019

States Pass Record Number Of Laws To Reel In Drug Prices

So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.

By Steven Findlay

Sept. 9, 2019

Listen: India Gives Opioid Makers A Huge And Growing New Market

KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.

Sept. 5, 2019

Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery

New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.

By Julie Appleby

Sept. 4, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Aug. 30, 2019

Postcard From Germany

Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore

Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.

By Shefali Luthra

Aug. 30, 2019

In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’

As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.

By Sarah Varney

Aug. 29, 2019

Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India

What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.

By Sarah Varney

Aug. 28, 2019

Pharma Cash To Congress

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.

By Emmarie Huetteman, Jay Hancock, and Elizabeth Lucas

Aug. 27, 2019

Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case

The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.

By Jackie Fortiér, StateImpact Oklahoma and Brian Mann, North Country Public Radio

Aug. 26, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Aug. 23, 2019

Letters To The Editor

Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Aug. 23, 2019

Podcast

KHN’s ‘What The Health?’: All About Medicare

Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.

Aug. 22, 2019

Asking Never Hurts

Shopping Abroad For Cheaper Medication? Here’s What You Need To Know

Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.

By Bernard J. Wolfson

Aug. 22, 2019

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs